Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 4 NIH 3 OTHER 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

apatinib 2 Immunotherapy 2 Drug Therapy 2 130-nm albumin-bound paclitaxel 2 toripalimab 1 spartalizumab 1 darolutamide 1 camrelizumab 1 Surgical Procedures, Operative 1 Standard of Care 1 Radiation 1 Platinum Compounds 1 Mitomycin 1 Low-Level Light Therapy 1 Lisaftoclax 1 Indocyanine Green 1 Gemcitabine 1 Everolimus 1 Cisplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Mitomycin × 30 days × Clear all

NCT06388720 2026-05-29

IMGeS

National Cancer Center, Korea

Phase 2 Recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡